Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines

A Brown; S Shah; S Dluzewski; B Musaddaq; T Wagner; T Szyszko; S Wan; A Groves; K Mokbel; A Malhotra

doi:10.1016/j.crad.2021.04.010

Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines

Clin Radiol. 2021 Aug;76(8):553-558. doi: 10.1016/j.crad.2021.04.010. Epub 2021 May 14.

Authors

A Brown¹, S Shah², S Dluzewski³, B Musaddaq³, T Wagner², T Szyszko², S Wan⁴, A Groves⁴, K Mokbel⁵, A Malhotra³

Affiliations

¹ Radiology Department, Royal Free Hospital, Pond Street, London, NW3 2QG, UK. Electronic address: adam.brown16@nhs.net.
² Department of Nuclear Medicine, Royal Free Hospital, London, NW3 2QG, UK.
³ Radiology Department, Royal Free Hospital, Pond Street, London, NW3 2QG, UK.
⁴ Institute of Nuclear Medicine, University College London, WC1E 6BT, UK.
⁵ London Breast Institute, The Princess Grace Hospital, 42-52 Nottingham Place, London, W1U 5NY, UK.

Abstract

We present a multimodality pictorial review of axillary lymphadenopathy in patients recently vaccinated against COVID-19. As the mass vaccination programme continues to be rolled out worldwide in an effort to combat the pandemic, it is important that radiologists consider recent COVID-19 vaccination in the differential diagnosis of unilateral axillary lymphadenopathy and are aware of typical appearances across all imaging methods. We review current guidelines on the management of unilateral axillary lymphadenopathy in the context of recent COVID-19 vaccination.

Publication types

Review

MeSH terms

Axilla / diagnostic imaging*
COVID-19 / prevention & control*
COVID-19 Vaccines*
Humans
Lymphadenopathy / chemically induced*
Lymphadenopathy / diagnostic imaging*
Mass Vaccination
Pandemics
Practice Guidelines as Topic*
SARS-CoV-2

Substances

COVID-19 Vaccines